| Volume 21, 2017 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 4
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
|
Jan/Feb 2017
Pg. 19-21
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Why You Should Become an International Academy of Compounding Pharmacists Member
Gates Ernest P Jr
|
Jan/Feb 2017
Pg. 28
|
Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 31-37
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Calculations
Stockton Shelly J
|
Jan/Feb 2017
Pg. 58-59
|
Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 60
|
Diazoxide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 61
|
Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 62
|
Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 63
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 65
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 66-75
|
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017
Pg. 76-82
|
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D, Vernak Charlene, Zhao Fang
|
Jan/Feb 2017
Pg. 83-87
|
PreScription: Whatever Happened to Common Sense?
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 92
|
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
|
Mar/Apr 2017
Pg. 95-102
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Consultation for Human, Veterinary, and Compounded Medications
Moghadam Gabriella, Forsythe Lauren Eichstadt
|
Mar/Apr 2017
Pg. 111-115
|
The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
|
Mar/Apr 2017
Pg. 116-117
|
Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 118-124
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Calculations
Stockton Shelly J
|
Mar/Apr 2017
Pg. 144
|
Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 146
|
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 147
|
Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 148
|
Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 149
|
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers
McCluskey Susan V, Kirkham Kylian, Munson Jessica M
|
Mar/Apr 2017
Pg. 150-153
|
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017
Pg. 154-159
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
|
Mar/Apr 2017
Pg. 171-175
|
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
|
May/Jun 2017
Pg. 180
|
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
|
May/Jun 2017
Pg. 182-190
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Rice Baylor
|
May/Jun 2017
Pg. 212-213
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
|
May/Jun 2017
Pg. 215-220
|
Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
|
May/Jun 2017
Pg. 223-228
|
Calculations
Stockton Shelly J
|
May/Jun 2017
Pg. 230-231
|
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 232
|
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 233
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
May/Jun 2017
Pg. 234
|
Meloxicam 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2017
Pg. 235
|
Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2017
Pg. 236
|
PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
|
May/Jun 2017
Pg. 237
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 239
|
Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
|
May/Jun 2017
Pg. 240-241
|
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
|
May/Jun 2017
Pg. 242-246
|
Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero
|
May/Jun 2017
Pg. 247-250
|
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
McHenry Adam R, Wempe Michael F, Rice Peter J
|
May/Jun 2017
Pg. 251-254
|
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
|
May/Jun 2017
Pg. 255-263
|
PreScription: Just Think About It!
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 268
|
Change Is In the Air: What You Need to Know About Pharmacy Ventilation Under United States Pharmacopeia <800>
Laniewicz Cheryl
|
Jul/Aug 2017
Pg. 271-274
|
Component Selection for Sterile Compounding
Dilzer Richard H
|
Jul/Aug 2017
Pg. 277-280
|
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
|
Jul/Aug 2017
Pg. 282-289
|
The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871
Rice Baylor
|
Jul/Aug 2017
Pg. 290-291
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Calculations
Stockton Shelly J
|
Jul/Aug 2017
Pg. 310
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 313
|
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 314
|
Disopyramide 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 315
|
Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 316
|
Reteplase Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 317
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Torsemide 10-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 320
|
Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 321
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
|
Jul/Aug 2017
Pg. 330-333
|
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Jul/Aug 2017
Pg. 334-338
|
Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4
de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
|
Jul/Aug 2017
Pg. 339-346
|
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia
Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
|
Jul/Aug 2017
Pg. 347-351
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Compounding Opportunities in Urology
Biundo Bruce
|
Sep/Oct 2017
Pg. 358-362
|
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Documentation: Records and Reports
Akers Michael J
|
Sep/Oct 2017
Pg. 373-380
|
IACP Legislative/Regulatory Update
International Academy of Compounding Pharmacists
|
Sep/Oct 2017
Pg. 382-383
|
Quality Control: Bar Codes and Bar Code Scanners for Unit-Dose Medications in a Healthcare Setting
Medi-Dose Inc./EPS Inc.
|
Sep/Oct 2017
Pg. 384-387
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Basics of Sterile Compounding: Particulate Matter
Akers Michael J
|
Sep/Oct 2017
Pg. 395-404
|
Calculations
Stockton Shelly J
|
Sep/Oct 2017
Pg. 406
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 409
|
Etoposide 20-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 410
|
Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 411
|
Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 412
|
Ioversol Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 413
|
Levocarnitine 100-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 414
|
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 415
|
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 416
|
Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 417
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes
Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
|
Sep/Oct 2017
Pg. 426-429
|
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt
Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Sep/Oct 2017
Pg. 430-435
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2017
Pg. 454-461
|
Features of Pharmaceutical Compounding in the Republic of Tajikistan
Alfred-Ugbenbo DS, Valiev AH, Zdoryk OA, Georgiyants VA
|
Nov/Dec 2017
Pg. 463-467
|
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
|
Nov/Dec 2017
Pg. 468
|
Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
|
Nov/Dec 2017
Pg. 471-479
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Calculations
Stockton Shelly J
|
Nov/Dec 2017
Pg. 488
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 491
|
Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 492
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 494
|
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 495
|
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 496
|
Tolmetin 400-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 497
|
Trace Elements Injection 5
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 498
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
|
Nov/Dec 2017
Pg. 500-512
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017
Pg. 518-529
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
| Return to Top |
